UPDATE 1-U.S. FDA panel supports Novartis version of Amgen arthritis drug

July 13 (Reuters) - Novartis AG's cheaper version

of Amgen Inc's arthritis drug Enbrel is highly similar

in potency and safety to the original and should be approved, an

advisory panel to the U.S....

Read more